Human dead box helicase 3 Couples IκB kinase ε to interferon regulatory factor 3 activation

Molecular and Cellular Biology

Volumn 33, Issue 10, 2013, Pages 2004-2015

  Gu, Lili ^a   Fullam, Anthony ^a   Brennan, Ruth ^a   Schröder, Martina ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

DEAD BOX HELICASE 3; DEAD BOX PROTEIN; HOST FACTOR; I KAPPA B KINASE EPSILON; INTERFERON REGULATORY FACTOR 3; UNCLASSIFIED DRUG; BETA INTERFERON; DDX3X PROTEIN, HUMAN; I KAPPA B KINASE; IRF3 PROTEIN, HUMAN; PEPTIDE FRAGMENT;

ARTICLE; AUTOPHOSPHORYLATION; DIMERIZATION; ENZYME ACTIVATION; HUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CELL STRAIN HEK293; CHEMISTRY; GENE EXPRESSION; GENETICS; METABOLISM; MOLECULAR GENETICS; PEPTIDE MAPPING; PHOSPHORYLATION; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROCESSING; REPORTER GENE; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION INITIATION;

HEPATITIS C VIRUS;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; DEAD-BOX RNA HELICASES; ENZYME ACTIVATION; GENE EXPRESSION; GENES, REPORTER; HEK293 CELLS; HUMANS; I-KAPPA B KINASE; INTERFERON REGULATORY FACTOR-3; INTERFERON-BETA; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PEPTIDE FRAGMENTS; PEPTIDE MAPPING; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN PROCESSING, POST-TRANSLATIONAL; TRANSCRIPTIONAL ACTIVATION;

MLCS; MLOWN;

EID: 84878194077     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01603-12     Document Type: Article

References (40)

1. Schröder M. 2010. Human DEAD-box protein 3 has multiple functions in gene regulation and cell cycle control and is a prime target for viral manipulation. Biochem. Pharmacol. 79:297-306.
2. Ariumi Y, Kuroki M, Abe K, Dansako H, Ikeda M, Wakita T, Kato N. 2007. DDX3 DEAD-box RNA helicase is required for hepatitis C virus RNA replication. J. Virol. 81:13922-13926.
3. Randall G, Panis M, Cooper JD, Tellinghuisen TL, Sukhodolets KE, Pfeffer S, Landthaler M, Landgraf P, Kan S, Lindenbach BD, Chien M, Weir DB, Russo JJ, Ju J, Brownstein MJ, Sheridan R, Sander C, Zavolan M, Tuschl T, Rice CM. 2007. Cellular cofactors affecting hepatitis C virus infection and replication. Proc. Natl. Acad. Sci. U. S. A. 104:12884 -12889.
4. Yedavalli VS, Neuveut C, Chi YH, Kleiman L, Jeang KT. 2004. Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function. Cell 119:381-392.
5. Oshiumi H, Sakai K, Matsumoto M, Seya T. 2010. DEAD/H BOX 3 (DDX3) helicase binds the RIG-I adaptor IPS-1 to up-regulate IFN-betainducing potential. Eur. J. Immunol. 40:940 -948.
6. Schroder M, Baran M, Bowie AG. 2008. Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKK-epsilon-mediated IRF activation. EMBO J. 27:2147-2157.
7. Soulat D, Burckstummer T, Westermayer S, Goncalves A, Bauch A, Stefanovic A, Hantschel O, Bennett KL, Decker T, Superti-Furga G. 2008. The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response. EMBO J. 27:2135-2146.
8. Wang H, Ryu W-S. 2010. Hepatitis B virus polymerase blocks pattern recognition receptor signaling via interaction with DDX3: implications for immune evasion. PLoS Pathog. 6:e1000986. doi:10.1371/journal.ppat. 1000986.
9. Yu S, Chen J, Wu M, Chen H, Kato N, Yuan Z. 2010. Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKe and DDX3. J. Gen. Virol. 91:2080 -2090.
10. Thompson MR, Kaminski JJ, Kurt-Jones EA, Fitzgerald KA. 2011. Pattern recognition receptors and the innate immune response to viral infection. Viruses 3:920 -940.
11. Kawai T, Akira S. 2007. Antiviral signaling through pattern recognition receptors. J. Biochem. 141:137-145.
12. O'Neill LA, Fitzgerald KA, Bowie AG. 2003. The Toll-IL-1 receptor adaptor family grows to five members. Trends Immunol. 24:286 -290.
13. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, Coyle AJ, Liao SM, Maniatis T. 2003. IKKe and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4:491-496.
14. Sharma S, ten Oever BR, Grandvaux N, Zhou Lin G-PR, Hiscott J. 2003. Triggering the interferon antiviral response through an IKK-related pathway. Science 300:1148 -1151.
15. Johnson CL, Gale Jr, M. 2006. CARD games between virus and host get a new player. Trends Immunol. 27:1-4.
16. Kato H, Sato S, Yoneyama M, Yamamoto M, Uematsu S, Matsui K, Tsujimura T, Takeda K, Fujita T, Takeuchi O, Akira S. 2005. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23: 19-28.
17. Clark K, Peggie M, Plater L, Sorcek RJ, Young ER, Madwed JB, Hough J, McIver EG, Cohen P. 2011. Novel cross-talk within the IKK family controls innate immunity. Biochem. J. 434:93-104.
18. Kalverda AP, Thompson GS, Vogel A, Schröder M, Bowie AG, Khan AR, Homans SW. 2009. Poxvirus K7 protein adopts a Bcl-2 fold: biochemical mapping of its interactions with human DEAD box RNA helicase DDX3. J. Mol. Biol. 385:843-853.
19. Oda S-i, Schröder M, Khan AR. 2009. Structural basis for targeting of human RNA helicase DDX3 by poxvirus protein K7. Structure 17:1528-1537.
20. Wang H, Kim S, Ryu WS. 2009. DDX3 DEAD-box RNA helicase inhibits hepatitis B virus reverse transcription by incorporation into nucleocapsids. J. Virol. 83:5815-5824.
21. Mamiya N, Worman HJ. 1999. Hepatitis C virus core protein binds to a DEAD box RNA helicase. J. Biol. Chem. 274:15751-15756.
22. Owsianka AM, Patel AH. 1999. Hepatitis C virus core protein interacts with a human DEAD box protein DDX3. Virology 257:330 -340.
23. You L-R, Chen C-M, Yeh T-S, Tsai T-Y, Mai R-T, Lin C-H, Lee Y-HW. 1999. Hepatitis C virus core protein interacts with cellular putative RNA helicase. J. Virol. 73:2841-2853.
24. Oshiumi H, Ikeda M, Matsumoto M, Watanabe A, Takeuchi O, Akira S, Kato N, Shimotohno K, Seya T. 2010. Hepatitis C virus core protein abrogates the DDX3 function that enhances IPS-1-mediated IFN-beta induction. PLoS One 5:e14258. doi:10.1371/journal.pone.0014258.
25. Servant MJ, Grandvaux N, ten Oever BR, Duguay D, Lin R, Hiscott J. 2003. Identification of the minimal phosphoacceptor site required for in vivo activation of interferon regulatory factor 3 in response to virus and double-stranded RNA. J. Biol. Chem. 278:9441-9447.
26. Kishore N, Huynh QK, Mathialagan S, Hall T, Rouw S, Creely D, Lange G, Caroll J, Reitz B, Donnelly A, Boddupalli H, Combs RG, Kretzmer K, Tripp CS. 2002. IKK-i and TBK-1 are enzymatically distinct from the homologous enzyme IKK-2. J. Biol. Chem. 277:13840 -13847.
27. Hogbom M, Collins R, van den Berg S, Jenvert RM, Karlberg T, Kotenyova T, Flores A, Karlsson Hedestam GB, Schiavone LH. 2007. Crystal structure of conserved domains 1 and 2 of the human DEAD-box helicase DDX3X in complex with the mononucleotide AMP. J. Mol. Biol. 372:150 -159.
28. Ryzhakov G, Randow F. 2007. SINTBAD, a novel component of innate antiviral immunity, shares a TBK1-binding domain with NAP1 and TANK. EMBO J. 26:3180 -3190.
29. Goncalves A, Bürckstümmer T, Dixit E, Scheicher R, Górna MW, Karayel E, Sugar C, Stukalov A, Berg T, Kralovics R, Planyavsky M, Bennett KL, Colinge J, Superti-Furga G. 2011. Functional dissection of the TBK1 molecular network. PLoS One 6:e23971. doi:10.1371/journal. pone.0023971.
30. Koop A, Lepenies I, Braum O, Davarnia P, Scherer G, Fickenscher H, Kabelitz D, Adam-Klages S. 2011. Novel splice variants of human IKKe negatively regulate IKKe-induced IRF3 and NF-kB activation. Eur. J. Immunol. 41:224 -234.
31. Hutti JE, Shen RR, Abbott DW, Zhou AY, Sprott KM, Asara JM, Hahn WC, Cantley LC. 2009. Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKe promotes cell transformation. Mol. Cell 34:461-472.
32. Obenauer JC, Cantley LC, Yaffe MB. 2003. Scansite 2.0: proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucleic Acids Res. 31:3635-3641.
33. Blom N, Gammeltoft S, Brunak S. 1999. Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J. Mol. Biol. 294: 1351-1362.
34. Clark K, Plater L, Peggie M, Cohen P. 2009. Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IκB kinase e. J. Biol. Chem. 284:14136 -14146.
35. Clark K, Takeuchi O, Akira S, Cohen P. 2011. The TRAF-associated protein TANK facilitates cross-talk within the IκB kinase family during Toll-like receptor signaling. Proc. Natl. Acad. Sci. U. S. A. 108:17093-17098.
36. Tanaka Y, Chen ZJ. 2012. STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway. Sci. Signal. 5:ra20.
37. Xu G, Lo Li Y-CQ, Napolitano G, Wu X, Jiang X, Dreano M, Karin M, Wu H. 2011. Crystal structure of inhibitor of κB kinase ε. Nature 472: 325-330.
38. Ma X, Helgason E, Phung QT, Quan CL, Iyer RS, Lee MW, Bowman KK, Starovasnik MA, Dueber EC. 2012. Molecular basis of Tank-binding kinase 1 activation by transautophosphorylation. Proc. Natl. Acad. Sci. U. S. A. 109:9378 -9383.
39. Chen W, Srinath H, Lam SS, Schiffer CA, Royer WE, Jr, Lin K. 2008. Contribution of Ser386 and Ser396 to activation of interferon regulatory factor 3. J. Mol. Biol. 379:251-260.
40. Ishikawa H, Ma Z, Barber GN. 2009. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461:788 -792.